GSTM1 and liver disorder: The guidelines advised that Hb levels should not exceed 12 g/dL, and that ESAs should be carefully reconsidered in patients with a high risk of thromboembolic events, used with caution in liver disease, and not given to patients with ESA hypersensitivity or poorly controlled hypertension (Schrijvers et al., 2010).